Naoero vs Samoa: New cases tested for RR-/MDR-TB

Naoero
100.0%
in 2023
Samoa
100.0%
in 2024
Naoero rank
1st
Samoa rank
1st

New cases tested for RR-/MDR-TB over time

  • Naoero
  • Samoa
020406080100200920162024

How they compare

Naoero currently reports 100.0% against 100.0% in Samoa, a difference of 0.0%.

Across all 8 years both countries report, Samoa has been ahead every year.

Naoero ranks 1st and Samoa ranks 1st of 192 countries.

Samoa has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Naoero Samoa Difference Ahead
2010s 0.0% 80.0% 80.0% Samoa
2020s 66.7% 66.7% 0.0%

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, Naoero or Samoa?
Naoero, at 100.0% against 100.0% in Samoa as of 2023.
What is the difference in new cases tested for rr-/mdr-tb between Naoero and Samoa?
0.0%, with Naoero ahead.
How many years of comparable data are there for Naoero and Samoa?
8 years are reported by both, from 2014 to 2022.
How do Naoero and Samoa rank globally for new cases tested for rr-/mdr-tb?
Naoero ranks 1st and Samoa ranks 1st of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Naoero vs Samoa: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 31 August 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/naoero/samoa/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/naoero/samoa/">Naoero vs Samoa: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
204 places, 3,368 data points, 2005–2024
Last refreshed